Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Nov 17, 2025 · Filed Nov 18, 2025
The boss of Exponent sold $226K of Exponent shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$226,411
Shares × reported transaction price
18 days after results of Oct 30, 2025, 80 days before results of Feb 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.4% | +2.6% | +3.9% |
| 30 days | +5.6% | +2.7% | +2.9% |
| 90 days | +0.8% | +3.0% | −2.3% |
| 180 days | −15.9% | +11.5% | −27.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.